Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Dell Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mohan Marette who wrote (38646)	4/22/1998 8:42:00 AM
From: tony 890	Read Replies (1) \| Respond to of 176387

Kemble, Congratulations! Thanks to Mohan, also.

To: Mohan Marette who wrote (38646)	4/22/1998 8:51:00 AM
From: Boplicity	Respond to of 176387

ot ot ot The below is how I love to see companies report numbers, From LU. Second Fiscal Quarter Income Statement (Unaudited; Millions of Dollars, except per share amounts) For Three Months Ended 3/31/98 3/31/98(a) 3/31/97 Change(b) ---------------------------------------------------------------------- Revenues 6,157 6,157 5,149 19.6% Costs 3,433 3,433 2,981 15.2% Gross Margin 2,724 2,724 2,168 25.6% Selling, General and Administrative 1,487 1,487 1,287 15.5% Research and Development 1,086 929 738 25.9% Total Operating Expenses 2,573 2,416 2,025 19.3% Operating Income 151 308 143 115.4% Other Income, net 47 47 40 17.5% Interest expense 74 74 77 (3.9%) Income before income taxes 124 281 106 165.1% Income tax expense 101 101 40 152.5% Net Income 23 180 66 172.7% Earnings per share-- Basic 0.02 0.14 0.05 180.0% Earnings per share-- Diluted 0.02 0.14 0.05 180.0% Effective tax rate (%) 81.5% 36.0% 38.1% (2.1) ---------------------------------------------------------------------- (a) Excludes one-time charge of $157 for purchased in-process R&D related to the acquisition of Prominet. (b) Change is between the three-month period ended 3/31/98, excluding one-time charge related to the acquisition of Prominet, and the corresponding 1997 period.